ECSP972130A - VITAMIN D3 ANALOGS - FLUORINATED - Google Patents

VITAMIN D3 ANALOGS - FLUORINATED

Info

Publication number
ECSP972130A
ECSP972130A ECSP972130A ECSP972130A EC SP972130 A ECSP972130 A EC SP972130A EC SP972130 A ECSP972130 A EC SP972130A EC SP972130 A ECSP972130 A EC SP972130A
Authority
EC
Ecuador
Prior art keywords
fluorinated
analogs
vitamin
hydroxyl
hydrogen
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972130 priority Critical patent/ECSP972130A/en
Publication of ECSP972130A publication Critical patent/ECSP972130A/en

Links

Abstract

Un compuesto de fórmula I (gráfico)en donde R es hidrógeno, flúor o hidroxilo, y x es =CH2 o cuando R es hidroxilo, X es hidrógeno ó =CH2 el cual es de utilidad en el tratamiento de trastornos hiperproliferativos, enfermedades neoplásicas y enfermedades de las glándulas sebáceas.A compound of formula I (graph) where R is hydrogen, fluorine or hydroxyl, and x is = CH2 or when R is hydroxyl, X is hydrogen or = CH2 which is useful in the treatment of hyperproliferative disorders, neoplastic diseases and diseases of the sebaceous glands.

ECSP972130 1997-05-22 1997-05-22 VITAMIN D3 ANALOGS - FLUORINATED ECSP972130A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972130 ECSP972130A (en) 1997-05-22 1997-05-22 VITAMIN D3 ANALOGS - FLUORINATED

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972130 ECSP972130A (en) 1997-05-22 1997-05-22 VITAMIN D3 ANALOGS - FLUORINATED

Publications (1)

Publication Number Publication Date
ECSP972130A true ECSP972130A (en) 1998-07-23

Family

ID=42042961

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972130 ECSP972130A (en) 1997-05-22 1997-05-22 VITAMIN D3 ANALOGS - FLUORINATED

Country Status (1)

Country Link
EC (1) ECSP972130A (en)

Similar Documents

Publication Publication Date Title
UY24563A1 (en) FLUORINATED ANALOGS OF VITAMIN D3
CA2205275A1 (en) Vitamin d3 analogs
BR0313371A (en) Compound, use of a compound and disease treatment method
HK1091112A1 (en) Compounds and methods for increasing neurogenesis
EP1432714A4 (en) Chemical compounds
ATE291351T1 (en) SUPEROXIDE DISMUTASE MEMETICS
PT892638E (en) FORMULATION TOPIC OF VITAMIN D BASED ON LIPOSOMES
DK0580968T3 (en) Fluorinated analogs of vitamin D3
BR0209541A (en) Use of 2-phenyl-substituted imidazotriazinones
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
MXPA03001081A (en) Anti-inflammatory medicament.
NO934197D0 (en) Vitamin D-3 analogues
ECSP972130A (en) VITAMIN D3 ANALOGS - FLUORINATED
PT1150703E (en) MULTIPLE SCLEROSIS THERAPY WITH CHAPERONINE 10 AND BETA-INTERFERENCE
ATE277924T1 (en) ARYL-8-AZABICYCLO(3.2.1)OCTANES FOR THE TREATMENT OF DEPRESSION
NO20005548L (en) Mykobakterieinhibitorer
ID27052A (en) ARTHRITIS TREATMENT AND OTHER CONDITIONS
EP1436279A4 (en) Chemical compounds
ECSP972129A (en) VITAMIN D3 ANALOGS
NO995132L (en) Method of reducing fibrinogen
MY112142A (en) Method of building architectural panels
UA23368A (en) Using (1,1-dioxothiolan-3-yl) potassium dithiocarbamate as an antimicrobial agent
AU2001262786A1 (en) Use of l-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes
ATE283255T1 (en) ACYLATING AGENT